CFG
IMNM icon

Citizens Financial Group’s Immunome IMNM Stock Holding History

Citizens Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Buy
20,000
+46
+0.2% +$984 0.01% 721
2026
Q1 		$436K Sell
19,954
-46
-0.2% -$1.02K 0.01% 574
2025
Q4 		$430K Hold
20,000
– – 0.01% 579
2025
Q3 		$234K Hold
20,000
– – ﹤0.01% 723
2025
Q2 		$186K Hold
20,000
– – ﹤0.01% 670
2025
Q1 		$135K Buy
+20,000
New +$192K ﹤0.01% 602

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Citizens Financial Group's IMNM Position: Q2 2026 in Review

Citizens Financial Group increased its Immunome (IMNM) stake by 0.23% in Q2 2026, buying an estimated $984 and bringing the position to 20,000 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #721.

Citizens Financial Group first reported a position in IMNM in Q1 2025 and has held it in 6 quarters since. The position peaked at $436K in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Citizens Financial Group held 20,000 shares of Immunome worth $424K as of Q2 2026.
  • Citizens Financial Group bought 46 Immunome shares in Q2 2026, an estimated $984.
  • Immunome made up 0.01% of Citizens Financial Group's portfolio in Q2 2026, its #721 holding.
  • Citizens Financial Group first reported a position in Immunome in Q1 2025 and has held it in 6 quarters since.
  • Citizens Financial Group's Immunome position peaked at $436K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.